Immunogenicity and Safety of Two Different Commercial EV71 Vaccines
Clinical trial NCT03873740 · COMPLETED
Trial details
- NCT number
- NCT03873740
- Sponsor
- Sinovac Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-06
- Primary completion
- 2019-01-21
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.